Literature DB >> 25796447

Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence.

Sabine Vértesy1, Malwina Michalak2, Michelle C Miller3, Martina Schnölzer4, Sabine André5, Jürgen Kopitz6, Kevin H Mayo7, Hans-Joachim Gabius1.   

Abstract

Lectins translate information encoded in glycan chains of cellular glycoconjugates into bioeffects. The topological presentation of contact sites for cognate sugar binding is a crucial factor toward this end. To dissect the significance of such phylogenetically conserved properties, the design and engineering of non-natural variants are attractive approaches. Here, a homodimeric human lectin, i.e. adhesion/growth-regulatory galectin-1, is converted into a tandem-repeat display by introducing the 33-amino-acid linker of another family member (i.e. galectin-8). The yield of variant was reduced by about a third. This protein had ∼10-fold higher activity in hemagglutination. Nearly complete sequence determination by mass-spectrometric in-source decay and fingerprinting excluded the presence of any modifications. When (1)H-(15)N heteronuclear single-quantum coherence data on the (15)N-labeled variant and wild-type protein were compared, changes in chemical shifts, signal intensities and resonance multiplicities revealed reduction of stability of interfacial contacts between the lectin domains and an increase in inter-domain flexibility. When both binding sites in the variant were loaded with ligand, association of the two carbohydrate recognition domains was enhanced, corroborated by gel filtration. Dynamic changes in the spatial presentation of the two lectin domains in the context of a tandem-repeat display can alter counterreceptor targeting relative to the fixed positions found in the proto-type galectin homodimer.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  hemagglutination; in-source decay; lectin; sugar code

Mesh:

Substances:

Year:  2015        PMID: 25796447     DOI: 10.1093/protein/gzv014

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  15 in total

Review 1.  From glycophenotyping by (plant) lectin histochemistry to defining functionality of glycans by pairing with endogenous lectins.

Authors:  Herbert Kaltner; Gabriel García Caballero; Anna-Kristin Ludwig; Joachim C Manning; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2018-05-05       Impact factor: 4.304

2.  Unraveling functional significance of natural variations of a human galectin by glycodendrimersomes with programmable glycan surface.

Authors:  Shaodong Zhang; Ralph-Olivier Moussodia; Sabine Vértesy; Sabine André; Michael L Klein; Hans-Joachim Gabius; Virgil Percec
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  How altering the modular architecture affects aspects of lectin activity: case study on human galectin-1.

Authors:  Tanja J Kutzner; Adele Gabba; Forrest G FitzGerald; Nadezhda V Shilova; Gabriel García Caballero; Anna-Kristin Ludwig; Joachim C Manning; Clemens Knospe; Herbert Kaltner; Fred Sinowatz; Paul V Murphy; Mare Cudic; Nicolai V Bovin; Hans-Joachim Gabius
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

4.  Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design.

Authors:  René Roy; Yihong Cao; Herbert Kaltner; Naresh Kottari; Tze Chieh Shiao; Karima Belkhadem; Sabine André; Joachim C Manning; Paul V Murphy; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2016-12-24       Impact factor: 4.304

Review 5.  Galectins: their network and roles in immunity/tumor growth control.

Authors:  Herbert Kaltner; Stefan Toegel; Gabriel García Caballero; Joachim C Manning; Robert W Ledeen; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2016-12-24       Impact factor: 4.304

Review 6.  Sweet complementarity: the functional pairing of glycans with lectins.

Authors:  H-J Gabius; J C Manning; J Kopitz; S André; H Kaltner
Journal:  Cell Mol Life Sci       Date:  2016-03-08       Impact factor: 9.261

7.  Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.

Authors:  Carlos A Orozco; Neus Martinez-Bosch; Pedro E Guerrero; Judith Vinaixa; Tomás Dalotto-Moreno; Mar Iglesias; Mireia Moreno; Magdolna Djurec; Françoise Poirier; Hans-Joachim Gabius; Martin E Fernandez-Zapico; Rosa F Hwang; Carmen Guerra; Gabriel A Rabinovich; Pilar Navarro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-03       Impact factor: 11.205

8.  Studying the Structural Significance of Galectin Design by Playing a Modular Puzzle: Homodimer Generation from Human Tandem-Repeat-Type (Heterodimeric) Galectin-8 by Domain Shuffling.

Authors:  Anna-Kristin Ludwig; Malwina Michalak; Nadya Shilova; Sabine André; Herbert Kaltner; Nicolai V Bovin; Jürgen Kopitz; Hans-Joachim Gabius
Journal:  Molecules       Date:  2017-09-19       Impact factor: 4.411

9.  Design-functionality relationships for adhesion/growth-regulatory galectins.

Authors:  Anna-Kristin Ludwig; Malwina Michalak; Qi Xiao; Ulrich Gilles; Francisco J Medrano; Hanyue Ma; Forrest G FitzGerald; William D Hasley; Adriel Melendez-Davila; Matthew Liu; Khosrow Rahimi; Nina Yu Kostina; Cesar Rodriguez-Emmenegger; Martin Möller; Ingo Lindner; Herbert Kaltner; Mare Cudic; Dietmar Reusch; Jürgen Kopitz; Antonio Romero; Stefan Oscarson; Michael L Klein; Hans-Joachim Gabius; Virgil Percec
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

10.  Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins.

Authors:  Hadi Mirzaei; Bahram Kazemi; Mojgan Bandehpour; Alireza Shoari; Vahid Asgary; Mehdi Shafiee Ardestani; Armin Madadkar-Sobhani; Reza Ahangari Cohan
Journal:  Drug Des Devel Ther       Date:  2016-03-16       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.